MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

$FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma$

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Avenacy announces launch of Eptifibatide for Injection in the U.S.

Viralgen Partners with Trogenix to Advance AAV Gene Therapy for Glioblastoma

07 May 2025

Viralgen, a leading contract development and manufacturing organization (CDMO) specializing in...

Ratio Therapeutics partners with Macrocyclics for exclusive production and global distribution of its Macropa™ radiopharmaceutical platform

Menarini Group Shares New Data on ELZONRIS® (tagraxofusp-erzs)

FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

Amazon Pharmacy Expands Same-Day Delivery and Kiosk Access for New Ozempic® Pill

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

By rainStorm Cell Therapeutics Inc.
rainStorm Cell Therapeutics Inc.
28 May 2026

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

By Nestlé Health Science U.S.
Nestlé Health Science U.S.
28 May 2026

Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed

By Ori Biotech
Ori Biotech
27 May 2026

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

By SK bioscience
SK bioscience
27 May 2026

Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

By LIB Therapeutics Inc.
LIB Therapeutics Inc.
27 May 2026

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

By H. Lundbeck A/S
H. Lundbeck A/S
26 May 2026

The Digital Pharma Advances Conference 2026

Most Popular

Aptar Pharma signs an exclusive agreement with Pulmotree to develop and promote the Kolibri™ non-propellant liquid inhaler platform

By Aptar Pharma

Sep 10
BARDA and Tiba Biotech Collaborate to Develop Next-Gen Influenza Therapeutics

By Tiba Biotech

Jul 11
ADARx doses first patient in Phase 3 STOP-HAE trial; ADX-324 receives orphan drug designation for hereditary angioedema

By ADARx Pharmaceuticals

Oct 22

May 2026

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Search your requirement

Social media

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

ProJenX announces the formation of its Clinical Advisory Board

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma

Featured Press Releases

Avenacy announces launch of Eptifibatide for Injection in the U.S.

Viralgen Partners with Trogenix to Advance AAV Gene Therapy for Glioblastoma

Ratio Therapeutics partners with Macrocyclics for exclusive production and global distribution of its Macropa™ radiopharmaceutical platform

Menarini Group Shares New Data on ELZONRIS® (tagraxofusp-erzs)

FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

Amazon Pharmacy Expands Same-Day Delivery and Kiosk Access for New Ozempic® Pill

BrainStorm Cell Therapeutics appoints Peter J. Pitts to its board.

Nestlé and IdB Holding S.p.A. sign VOWST® licensing deal in Europe

Ori Biotech and ImmuXell Announce Strategic Partnership and First Patient Dosed

SK bioscience Signs Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America

Presentations Highlight Results on LEROCHOL® (lerodalcibep-liga) Announced by LIB Therapeutics

Lundbeck Receives Marketing Authorization in South Korea for Vyepti® (eptinezumab) for the Preventive Treatment of Migraine

Most Popular

Aptar Pharma signs an exclusive agreement with Pulmotree to develop and promote the Kolibri™ non-propellant liquid inhaler platform

BARDA and Tiba Biotech Collaborate to Develop Next-Gen Influenza Therapeutics

ADARx doses first patient in Phase 3 STOP-HAE trial; ADX-324 receives orphan drug designation for hereditary angioedema

User Area

Discover

Engage with Us

Search your requirement

Social media

Featured Press Releases

Most Popular

User Area

Discover

Engage with Us

Subscribe to Our Monthly Newsletter